| Regimens Selected in Weisenthal Dataset | |
| in Platinum-Resistant Ovarian Cancer | |
| Drug/Combination | # of Times Selected |
| Pan-Resistant ->Angiogenesis Inhibitor? | 8 |
| Gemcitabine/Platinum | 8 |
| Topotecan (single) | 6 |
| Doxil (single) | 5 |
| Gemcitabine/Melphalan | 4 |
| Carboplatin or Cisplatin (single) | 3 |
| Ifosfamide or Cyclophosphamide (single) | 3 |
| 5FU (or Capecitabine) | 2 |
| Doxil/Cyclophosphamide | 2 |
| Etoposide (single) | 2 |
| Gemcitabine/Cisplatin/5FU | 2 |
| Gemcitabine/Doxil | 2 |
| Mitoxantrone/Vinorelbine | 2 |
| Platinum/Etoposide | 2 |
| Taxol (single) | 2 |
| Taxol/Vinorelbine | 2 |
| Topotecan/Cisplatin | 2 |
| 5FU/Inteferon alpha | 1 |
| Cisplatin/5FU | 1 |
| Cisplatin/Cyclophosphamide | 1 |
| Cisplatin/Interferon alpha | 1 |
| Cyclophosphamide/5FU | 1 |
| Doxil/Cisplatin | 1 |
| Doxil/Vinorelbine | 1 |
| Etoposide/5FU/Leucovorin | 1 |
| Gemcitabine/5FU | 1 |
| Gemcitabine/Cyclophosphamide | 1 |
| Gemcitabine/Etoposide | 1 |
| Gemcitabine/Taxol | 1 |
| Gemcitabine/Topotecan | 1 |
| Irinotecan/Gemcitabine ("Irinogem") | 1 |
| Irinotecan/Mitomicin C | 1 |
| Melphalan (single) | 1 |
| Mitoxantrone/Cyclophosphamide | 1 |
| Taxol/5FU | 1 |
| Total | 75 |